Cargando…
Rapid characterization of adeno-associated virus (AAV) gene therapy vectors by mass photometry
Recombinant adeno-associated viruses (rAAV) are used extensively as gene delivery vectors in clinical studies, and several rAAV based treatments have already been approved. Significant progress has been made in rAAV manufacturing; however, better and more precise capsid characterization techniques a...
Autores principales: | Wu, Di, Hwang, Philsang, Li, Tiansen, Piszczek, Grzegorz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296698/ https://www.ncbi.nlm.nih.gov/pubmed/35046529 http://dx.doi.org/10.1038/s41434-021-00311-4 |
Ejemplares similares
-
Size Exclusion Chromatography–Mass Photometry: A New Method for Adeno-Associated Virus Product Characterization
por: Wu, Di, et al.
Publicado: (2023) -
Quantification of Empty, Partially Filled and Full Adeno-Associated Virus Vectors Using Mass Photometry
por: Wagner, Christina, et al.
Publicado: (2023) -
Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
por: Naso, Michael F., et al.
Publicado: (2017) -
Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
por: Sen, Dwaipayan, et al.
Publicado: (2013) -
Gene therapy of adeno‐associated virus (AAV) vectors in preclinical models of ischemic stroke
por: Wang, Jing, et al.
Publicado: (2023)